| Treatment | NW | NE | SE | SW |
|---|---|---|---|---|
| Oral corticosteroid (prednisolone) | 6,169 (60%) | 690 (7%) | 2,782 (29%) | 359 (4%) |
| Inhaled corticosteroid (fluticasone) | 7,360 (73%) | 618 (6%) | 1,920 (20%) | 102 (1%) |
| NSAID (ibuprofen) | 7,533 (76%) | 221 (2%) | 2,049 (20%) | 196 (2%) |
| “No treatment” | 7,611 (77%) | 235 (2%) | 2,093 (20%) | 61 (1%) |
NW, north-west, more expensive and less effective than azithromycin; NE, north-east, more expensive and more effective than azithromycin; SW, south-west, less expensive and less effective than azithromycin; SE, south-east, less expensive and more effective than azithromycin
From: Appendix K, Health Economics
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.